Miller School of Medicine, University of Miami, Miami, FL, USA.
Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, FL, USA.
Surv Ophthalmol. 2023 Mar-Apr;68(2):280-289. doi: 10.1016/j.survophthal.2022.06.003. Epub 2022 Jul 4.
Inflammasomes are multicomplex molecular regulators with an emerging importance in regulating ocular surface and anterior segment health and disease. Key components found in the eye include NF-κB, NLRP3, NLRC4, NLRP6, ASC, IL-1β, IL-18, and caspase-1. The role of NLRP1, NLRC4, AIM2, and NLRP3 inflammasomes in the pathogenesis of infectious ulcers, DED, uveitis, glaucoma, corneal edema, and other diseases is being studied with many developments. Attenuation of these diseases has been explored by blocking various molecules along the inflammasome pathway with agents like NAC, polydatin, calcitriol, glyburide, YVAD, and disulfiram. We provide a background on the inflammasome pathway as it relates to the ocular surface and anterior segment of the eye, discuss the role of inflammasomes in the above diseases in animals and humans, investigate new therapeutic targets, and explore the efficacy of new anti-inflammasome therapies.
炎症小体是一种多复合物分子调节剂,在调节眼表面和前节健康和疾病方面具有重要作用。在眼睛中发现的关键成分包括 NF-κB、NLRP3、NLRC4、NLRP6、ASC、IL-1β、IL-18 和 caspase-1。NLRP1、NLRC4、AIM2 和 NLRP3 炎症小体在感染性溃疡、DED、葡萄膜炎、青光眼、角膜水肿和其他疾病的发病机制中的作用正在通过用 NAC、虎杖苷、骨化三醇、格列吡嗪、YVAD 和双硫仑等药物阻断炎症小体途径中的各种分子进行研究。我们提供了与眼表面和眼前节相关的炎症小体途径的背景知识,讨论了炎症小体在动物和人类上述疾病中的作用,研究了新的治疗靶点,并探讨了新的抗炎症小体治疗的疗效。